“If you haven’t heard about BioLargo in a while, then you
only know half the story,” said BioLargo CEO Dennis P. Calvert. “We’ve grown
into a serious contender in the cleantech solutions industry, and we have new
water remediation technologies that can help solve a lot of pressing challenges
in the world. We are excited to share our progress with the markets as we
continue to provide knockout solutions to challenging global problems.”
Benzinga hosts investor conferences focused on clean
technologies, also known as “cleantech”, which are technologies that foster
positive environmental outcomes such as reduced energy usage, water resource
stewardship, and minimization of waste. Industry leaders around the world are
increasingly focused on cleantech as the demand for these technologies rises
globally each year.
Sign up for free: https://www.benzinga.com/events/small-cap/clean-tech/
About the Benzinga Cleantech Small Cap Conference
The Benzinga Cleantech Small Cap Conference bridges the gap
between cleantech companies, investors, and traders. Discover the companies in
the cleantech industry who are moving the world forward through accessible
green energy, energy efficiency, and innovative sustainability solutions.
About BioLargo, Inc.
BioLargo, Inc. (OTCQB:BLGO) invents, develops, and commercializes
innovative platform technologies to solve challenging environmental problems
like PFAS contamination, advanced water and wastewater treatment, industrial
odor and VOC control, air quality control, and infection control. With over 13
years of extensive R&D, BioLargo holds a wide array of issued patents,
maintains a robust pipeline of products, and provides full-service
environmental engineering. Our peer-reviewed scientific approach allows us to
invent or acquire novel technologies and develop them to maturity through our
operating subsidiaries. With a keen emphasis on collaborations with academic,
municipal, and commercial organizations and associations, BioLargo has proven
itself with over 80 awarded grants and numerous pilot projects. We monetize
through direct sales, recurring service contracts, licensing agreements,
strategic joint venture formation and/or the sale of the IP. Several of our
technologies are commercially available and are advancing as disrupters in their
respective markets. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. These
forward-looking statements include without limitation those about BioLargo’s
(the “Company”) expectations regarding the impact of the COVID-19 pandemic;
anticipated revenue; and plans for future operations. These statements involve
risks and uncertainties, and actual results may differ materially from any
future results expressed or implied by the forward-looking statements. Risks
and uncertainties include without limitation: the effect of the COVID-19
pandemic on the Company’s business, results of operations, financial condition,
and stock price; the effect of regional economic conditions on the Company’s
business, including effects on purchasing decisions by consumers and
businesses; the ability of the Company to compete in markets that are highly
competitive and subject to rapid technological change; the ability of the
Company to manage frequent introductions and transitions of products and
services, including delivering to the marketplace, and stimulating customer
demand for, new products, services, and technological innovations on a timely
basis; the dependency of the Company on the performance of distributors of the
Company’s products. More information on these risks and other potential factors
that could affect the Company’s business and financial results is included in
the Company’s filings with the SEC, including in the “Risk Factors” and
“Management’s Discussion and Analysis of Financial Condition and Results of Operations”
sections of the Company’s most recently filed periodic reports on Form 10-K and
Form 10-Q and subsequent filings. The Company assumes no obligation to update
any forward-looking statements or information, which speak as of their
respective dates.
No comments:
Post a Comment